
搜索文档
XWELL, Inc. to Report Second Quarter 2025 Results on Thursday, August 14, 2025
Globenewswire· 2025-08-14 04:30
Webcast and Conference Call Scheduled for 5:00 PM ETNEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced that it will report second quarter 2025 financial results on Thursday, August 14, 2025, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m. ET. The Company encourages investors, and interested parties, to listen via webcast, as th ...
Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Corporate Update
Globenewswire· 2025-08-14 04:30
- Positive 12-month Phase 1/2 clinical data in adult cohort and early pediatric clinical data support potential for meaningful vision restoration with OPGx-LCA5 -- FDA grants Regenerative Medicine Advanced Therapy (RMAT) designation for OPGx-LCA5 - - Positive topline results reported from VEGA-3 and LYNX-2 Phase 3 trials with Phentolamine Ophthalmic Solution 0.75% - - OPGx-BEST1 on track to enter Phase 1/2 trial in H2 2025 for the treatment of bestrophin-1 related inherited retinal disease - - Non-dilutive ...
Ibotta, Inc.(IBTA) - 2025 Q2 - Earnings Call Presentation
2025-08-14 04:30
Earnings presentation Second quarter 2025 $1.30 back Add offer © 2025 Ibotta, Inc. Proprietary and confidential, not to be shared without Ibotta's express consent. Disclaimer This presentation is made by Ibotta, Inc. (the "Company," "Ibotta," "our," or "we") and contains forward-looking statements that involve substantial risks and uncertainties. All statements other than historical factual information are forward-looking statements, including without limitation statements regarding: future operating result ...
MSA Safety Names Julie A. Beck Senior Vice President, Chief Financial Officer and Treasurer
Prnewswire· 2025-08-14 04:30
PITTSBURGH, Aug. 13, 2025 /PRNewswire/ -- MSA Safety Incorporated (NYSE: MSA), a global leader in the development of advanced safety products and solutions that protect people and facility infrastructures, today announced that Julie A. Beck has been named Senior Vice President, Chief Financial Officer and Treasurer, effective August 18, 2025. Ms. Beck previously served as Senior Vice President and Chief Financial Officer for Terex Corp., a global industrial equipment manufacturer of materials processing mac ...
Expion360 (XPON) - 2025 Q2 - Earnings Call Presentation
2025-08-14 04:30
Industry Leader in Lithium Battery Power Solutions Second Quarter 2025 Financial Results Conference Call Corporate Presentation 1 NASDAQ: XPON August 13, 2025 Important Cautions & Disclaimers Certain statements contained in this presentation (this "Presentation") are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which statements are subject to considerable risks and uncertainties. Ex ...
Aptose Reports Second Quarter 2025 Results
Globenewswire· 2025-08-14 04:30
Tuspetinib Continues to Demonstrate Excellent Safety and Complete Responses in the TUSCANY Clinical Trial of Tuspetinib in AML Triple Drug Frontline Therapy at 120 mg Dose Cohort Safety Review Committee (CSRC) Recommends Tuspetinib Dose Escalation to 160 mg Dose Hanmi Continues to Support Development of Tuspetinib SAN DIEGO and TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company developing a tus ...
SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Globenewswire· 2025-08-14 04:30
First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical hold, triggering a $10M milestone payment from GSK. An additional $20M milestone will be triggered upon the six month anniversary of the new patient dosing; as previously disclosed GSK disputes these milestone payments. SCYNEXIS vigorously disagrees with GSK’s position and is working towards resolving this disagreement; SCYNEXIS is actively working with GSK to transfer the BREXAFEMME New Drug Application (NDA) to GSK b ...
Planet 13 Announces Q2 2025 Financial Results
Globenewswire· 2025-08-14 04:30
Q2 2025 Revenue of $26.9 millionQ2 2025 Net loss of $13.3 millionQ2 2025 Adjusted EBITDA loss of $2.4 million All figures are reported in United States dollars ($) unless otherwise indicated LAS VEGAS, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced its financial results for the three-month period ended June 30, 2025. Planet 13’s financial statements are prepared ...
CI&T Inc(CINT) - 2025 Q2 - Earnings Call Presentation
2025-08-14 04:30
Q2/25 investors .ciandt.com Hello, We are your CI&T presenters today: Cesar Gon Founder & CEO Bruno Guicardi Founder & NAE President Stanley Rodrigues Partner, CFO Eduardo Galvão IR Director Submit your question via email to investors@ciandt.com Q&A SESSION investors.ciandt.com SAFE HARBOR AND NON-IFRS MEASURES FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995 ...
MDU Resources Announces Appointments to the Board of Directors
Prnewswire· 2025-08-14 04:30
BISMARCK, N.D., Aug. 13, 2025 /PRNewswire/ -- MDU Resources Group, Inc. (NYSE: MDU) today announced the election of Charles M. Kelley and Tammy J. Miller to its board of directors, effective Aug. 12, 2025.Kelley brings more than four decades of experience in the natural gas industry, including a distinguished 25-year career at ONEOK, Inc., where he most recently served as senior vice president of Natural Gas Pipelines. He led strategic growth initiatives and commercial activities for ONEOK's natural gas pip ...